Related references
Note: Only part of the references are listed.Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
James D. Doecke et al.
ARCHIVES OF NEUROLOGY (2012)
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2011)
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
Stephen D. Weigand et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Multiple imputation by chained equations: what is it and how does it work?
Melissa J. Azur et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2011)
Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging
V. B. Gupta et al.
NEUROLOGY (2011)
A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
Sid E. O'Bryant et al.
PLOS ONE (2011)
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J. Jagust et al.
ALZHEIMERS & DEMENTIA (2010)
A Serum Protein-Based Algorithm for the Detection of Alzheimer Disease
Sid E. O'Bryant et al.
ARCHIVES OF NEUROLOGY (2010)
Plasma β-Amyloid and Cognitive Decline
Stephanie A. Cosentino et al.
ARCHIVES OF NEUROLOGY (2010)
CSF biomarkers in Alzheimer's disease - use in clinical diagnosis and to monitor treatment effects
K. Blennow
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Amyloid-beta Peptides in Plasma and Cognitive Decline After 1 Year Follow-Up in Alzheimer's Disease Patients
Christoph Laske et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
James K. Lui et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Blood-Borne Amyloid-β Dimer Correlates with Clinical Markers of Alzheimer's Disease
Victor L. Villemagne et al.
JOURNAL OF NEUROSCIENCE (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P. Bourgeat et al.
NEUROLOGY (2010)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Quits and Job Changes Among Home Care Workers in Maine: The Role of Wages, Hours, and Benefits
Lisa Morris
GERONTOLOGIST (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Plasma β amyloid and the risk of Alzheimer disease and dementia in elderly men
Johan Sundelof et al.
ARCHIVES OF NEUROLOGY (2008)
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
O. L. Lopez et al.
NEUROLOGY (2008)
A beta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
V. L. Villemagne et al.
NEUROPSYCHOLOGIA (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
β-amyloid imaging and memory in non-demented individuals:: evidence for preclinical Alzheimer's disease
Kerryn E. Pike et al.
BRAIN (2007)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Human pancreatic polypeptide has a marked diurnal rhythm that is affected by ageing and is associated with the gastric TFF2 circadian rhythm
C. Emma Johns et al.
PEPTIDES (2006)
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Colin L. Masters et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control
PT Schmidt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Minireview: Gut peptides regulating satiety
MR Druce et al.
ENDOCRINOLOGY (2004)
Plasma Aβ40 and Aβ42 and Alzheimer's disease -: Relation to age, mortality, and risk
R Mayeux et al.
NEUROLOGY (2003)
Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
RA Frank et al.
NEUROBIOLOGY OF AGING (2003)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
PD Mehta et al.
NEUROSCIENCE LETTERS (2001)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
